Prostate cancer decisions — 2026

The Veteran's vertigo is granted as service-connected, and the other issues on appeal are denied.

The Veteran's prostate cancer residuals, fecal incontinence, and renal pelvic tumor are all granted. The prostate cancer is rated at 60 percent, the fecal incontinence as secondary to prostate cancer treatment, and the renal pelvic tumor as secondary to prostate cancer treatment.

The Veteran's claim for an earlier effective date for prostate cancer associated with herbicide exposure prior to July 14, 2011 is denied.,An increased rating of 40 percent for service-connected prostate cancer is granted.

The Board denied the Veteran's claims for earlier effective dates and increased ratings, finding no legal basis to award such. The Veteran was granted service connection for voiding dysfunction, prostate cancer residuals, and erectile dysfunction on November 6, 2020, with a noncompensable rating for ED.

The Board has granted a TDIU effective December 1, 2022 due to the Veteran's service-connected disabilities preventing him from obtaining and maintaining suitable employment. The decision is based on his hypertension, prostate cancer, and other specified trauma/stressor-related disorder.

The Veteran's service-connected conditions have rendered him in need of regular aid and attendance, which is granted for special monthly compensation.

The Board has decided to remand the Veteran's claim for prostate cancer as it is not clear if his exposure to asbestos during service caused his current condition. The case will be sent back for a VA examination to determine the nature and etiology of his prostate cancer.

The Board has granted service connection for prostate cancer, finding that the Veteran was exposed to herbicide agents during his service at Fort Drum in 1967 and that this exposure is presumed due to Agent Orange use. The decision also acknowledges the Veteran's diagnosis of prostate cancer.

The Board has granted service connection for bilateral lower extremity radiculopathy and denied service connection for type II diabetes mellitus and prostate cancer. The decision is based on the Veteran's diagnosed conditions and their relationship to his service-connected lumbar spine disability.

The Veteran's prostatitis and prostate cancer are already rated at the maximum (100%) prior to January 1, 2021. The rating is restored effective that date.,A compensable disability rating for impotence has been denied.,PTSD from September 28, 2021, warrants a 100% disability rating.,Special monthly compensation based on housebound criteria was granted starting January 1, 2021.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there is no evidence to support a link between his current condition and his military service. The Board also found no exposure to toxic exposures during service.

The Veteran's TDIU claim due to asbestosis is granted, effective from August 28, 2022. The evidence shows that the Veteran's asbestosis significantly impacted his ability to work.

The Veteran's appeal for a disability rating in excess of 60 percent for diabetic nephropathy was denied as the appeal was not timely filed. The proposed reduction of his prostate cancer rating from 100% to 0% effective May 1, 2026, is deemed proper.

The Veteran's prostate cancer is found to be permanently disabling and total, meeting the criteria for a permanent total disability rating.

The Veteran's claims for service connection for non-Hodgkin lymphoma, bilateral hearing loss, tinnitus, and prostate cancer are granted. The Veteran's claim for an initial compensable rating for non-Hodgkin lymphoma is denied.

The Board has granted earlier effective dates of December 21, 2020 for the grants of service connection for prostate cancer, erectile dysfunction, and prostate cancer scar. The Veteran's claims are remanded for further action on downstream issues.

The Board has dismissed the appeal because it was a duplicate filing and improperly docketed with the Board.

The Veteran's bladder cancer, leukemia, and prostate cancer are not related to his service. The Board found no evidence of toxic exposures or a causal relationship between the conditions and service.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence to support a link between his prostate cancer and his military service or exposure to contaminated water at Camp Lejeune.

The Veteran's claim for an increased rating for bilateral hearing loss has been denied. The claims of service connection for prostate cancer, eye condition, and varicose veins have been remanded.